One year in review
One year in review 2020: systemic lupus erythematosus
V. Signorini1, E. Elefante2, D. Zucchi3, F. Trentin4, A. Bortoluzzi5, C. Tani6
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. violasignorini@hotmail.it
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa; and Department of Medical Biotechnologies, University of Siena, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
CER13336
2020 Vol.38, N°4
PI 0592, PF 0601
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 32662410 [PubMed]
Received: 18/03/2020
Accepted : 27/05/2020
In Press: 10/07/2020
Published: 28/07/2020
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a relapsing-remitting course that can affect various organs or systems, leading to a broad spectrum of clinical manifestations. In the past year, many studies have been published on SLE, providing a significant advancement in disease knowledge and patient management. The aim of this review is to summarise the most relevant scientific contributions on SLE pathogenesis, clinical manifestations and comorbidities, biomarkers and treatment strategies published in 2019.
